US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist
  • 0.519
  • +0.028+5.70%
Trading Nov 26 15:22 ET
12.00MMarket Cap-161P/E (TTM)

Turnstone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-73.66%19.31M
0
0
0
80.13%19.31M
-27.64%73.3M
10.45M
Operating revenue
--0
--0
--0
-73.66%19.31M
--0
--0
--0
80.13%19.31M
-27.64%73.3M
--10.45M
Cost of revenue
Gross profit
Operating expense
-2.97%18.37M
0.94%22.06M
5.03%20.69M
-25.34%78.34M
-27.32%17.86M
-28.54%18.93M
-28.28%21.85M
-15.81%19.7M
53.63%104.93M
24.57M
Selling and administrative expenses
-17.11%3.94M
-7.13%4.33M
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
-General and administrative expense
-17.11%3.94M
-7.13%4.33M
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
Research and development costs
1.78%14.42M
3.12%17.73M
0.78%15.79M
-30.23%60.49M
-33.42%13.46M
-33.31%14.17M
-35.21%17.19M
-16.22%15.67M
58.35%86.7M
--20.21M
Operating profit
2.97%-18.37M
-0.94%-22.06M
-5,151.52%-20.69M
-86.66%-59.03M
-26.46%-17.86M
-16.34%-18.93M
-290.91%-21.85M
96.89%-394K
-195.86%-31.63M
-14.12M
Net non-operating interest income expense
Other net income (expense)
-67.05%520K
117.58%755K
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
468K
Other non- operating income (expenses)
-67.05%520K
117.58%755K
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
--468K
Income before tax
-2.86%-17.85M
0.94%-21.3M
-139,992.86%-19.61M
-80.78%-55.49M
-21.70%-16.62M
-7.97%-17.35M
-284.97%-21.51M
99.89%-14K
-191.07%-30.69M
-13.65M
Income tax
-2,372.73%-816K
133.33%2K
119.51%16K
-302.84%-286K
-1,200.00%-165K
-141.25%-33K
-123.08%-6K
-510.00%-82K
-67.36%141K
15K
Net income
1.66%-17.03M
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
Net income continuous Operations
1.66%-17.03M
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
---13.67M
Minority interest income
Net income attributable to the parent company
1.66%-17.03M
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
Preferred stock dividends
Other preferred stock dividends
0
0
0
68K
Net income attributable to common stockholders
1.66%-17.03M
0.91%-21.3M
-19.63M
-79.02%-55.2M
-20.08%-16.41M
-7.23%-17.32M
-285.34%-21.5M
0
-192.68%-30.83M
-13.67M
Basic earnings per share
26.00%-0.74
5.05%-0.92
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
Diluted earnings per share
26.00%-0.74
5.05%-0.92
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 -73.66%19.31M 0 0 0 80.13%19.31M -27.64%73.3M 10.45M
Operating revenue --0 --0 --0 -73.66%19.31M --0 --0 --0 80.13%19.31M -27.64%73.3M --10.45M
Cost of revenue
Gross profit
Operating expense -2.97%18.37M 0.94%22.06M 5.03%20.69M -25.34%78.34M -27.32%17.86M -28.54%18.93M -28.28%21.85M -15.81%19.7M 53.63%104.93M 24.57M
Selling and administrative expenses -17.11%3.94M -7.13%4.33M 21.55%4.9M -2.06%17.85M 1.03%4.4M -9.20%4.76M 18.49%4.66M -14.18%4.03M 34.53%18.22M --4.35M
-General and administrative expense -17.11%3.94M -7.13%4.33M 21.55%4.9M -2.06%17.85M 1.03%4.4M -9.20%4.76M 18.49%4.66M -14.18%4.03M 34.53%18.22M --4.35M
Research and development costs 1.78%14.42M 3.12%17.73M 0.78%15.79M -30.23%60.49M -33.42%13.46M -33.31%14.17M -35.21%17.19M -16.22%15.67M 58.35%86.7M --20.21M
Operating profit 2.97%-18.37M -0.94%-22.06M -5,151.52%-20.69M -86.66%-59.03M -26.46%-17.86M -16.34%-18.93M -290.91%-21.85M 96.89%-394K -195.86%-31.63M -14.12M
Net non-operating interest income expense
Other net income (expense) -67.05%520K 117.58%755K 183.68%1.08M 280.06%3.55M 165.17%1.24M 689.00%1.58M 92.78%347K 347.06%380K 31.78%933K 468K
Other non- operating income (expenses) -67.05%520K 117.58%755K 183.68%1.08M 280.06%3.55M 165.17%1.24M 689.00%1.58M 92.78%347K 347.06%380K 31.78%933K --468K
Income before tax -2.86%-17.85M 0.94%-21.3M -139,992.86%-19.61M -80.78%-55.49M -21.70%-16.62M -7.97%-17.35M -284.97%-21.51M 99.89%-14K -191.07%-30.69M -13.65M
Income tax -2,372.73%-816K 133.33%2K 119.51%16K -302.84%-286K -1,200.00%-165K -141.25%-33K -123.08%-6K -510.00%-82K -67.36%141K 15K
Net income 1.66%-17.03M 0.91%-21.3M -28,966.18%-19.63M -79.02%-55.2M -20.36%-16.45M -7.23%-17.32M -285.34%-21.5M 100.54%68K -192.68%-30.83M -13.67M
Net income continuous Operations 1.66%-17.03M 0.91%-21.3M -28,966.18%-19.63M -79.02%-55.2M -20.36%-16.45M -7.23%-17.32M -285.34%-21.5M 100.54%68K -192.68%-30.83M ---13.67M
Minority interest income
Net income attributable to the parent company 1.66%-17.03M 0.91%-21.3M -28,966.18%-19.63M -79.02%-55.2M -20.36%-16.45M -7.23%-17.32M -285.34%-21.5M 100.54%68K -192.68%-30.83M -13.67M
Preferred stock dividends
Other preferred stock dividends 0 0 0 68K
Net income attributable to common stockholders 1.66%-17.03M 0.91%-21.3M -19.63M -79.02%-55.2M -20.08%-16.41M -7.23%-17.32M -285.34%-21.5M 0 -192.68%-30.83M -13.67M
Basic earnings per share 26.00%-0.74 5.05%-0.92 -0.85 -243.98%-4.78 -18.52%-0.73 -37.38%-1 -285.34%-0.9689 0 -192.68%-1.3896 -0.6159
Diluted earnings per share 26.00%-0.74 5.05%-0.92 -0.85 -243.98%-4.78 -18.52%-0.73 -37.38%-1 -285.34%-0.9689 0 -192.68%-1.3896 -0.6159
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data